NOVAMETRIX MEDICAL SYSTEMS INC
DEFA14A, 1996-11-12
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: HBO & CO, 10-Q, 1996-11-12
Next: NOVAMETRIX MEDICAL SYSTEMS INC, DEFA14A, 1996-11-12




<PAGE>
                        SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant  [X]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ]    Preliminary Proxy Statement
[ ]    Confidential, for Use of the Commission Only (as permitted by Rule
       14a-6(e)(2))
[ ]    Definitive Proxy Statement Confidential
[X]    Definitive Additional Materials
[ ]    Soliciting Material Pursuant to section 240.14a-11(c) or section 
       240.14a-12

                     NOVAMETRIX MEDICAL SYSTEMS INC.

 ...............................................................................
           (Name of Registrant as Specified In Its Charter)

 ...............................................................................
    (Name of Person(s) Filing Proxy Statement if Other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[ ]    $125 per Exchange Act Rule 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(j)(2).
[ ]    $500 per each party to the controversy pursuant to Exchange Act 
       Rule 14a-6(i)(3).
[ ]    Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

    1)    Title of each class of securities to which transaction applies:

    2)    Aggregate number of securities to which transaction applies:

    3)    Per unit price or other underlying value of transaction computed 
          pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
          filing fee is calculated and state how it was determined):

    4)    Proposed maximum aggregate value of transaction:

    5)    Total fee paid:

   [X]    Fee previously paid with preliminary materials.

[ ]    Check box if any part of the fee is offset as provided by Exchange Act 
       Rule 0-11(a)(2) and identify the filing for which the offsetting fee 
       was paid previously.  Identify the previous filing by registration 
       statement number, or the form or schedule and the date of its filing.


    1)    Amount Previously Paid:
            
          .....................................................................

    2)    Form, Schedule or Registration Statement No.:

          .....................................................................

    3)    Filing Party:
            
          .....................................................................

    4)    Date Filed:
            
          .....................................................................



<PAGE>
                 AN IMPORTANT BULLETIN FOR
                 NOVAMETRIX MEDICAL SYSTEMS
                        STOCKHOLDERS

                     -------------------

AS YOU CONSIDER YOUR VOTE AT THE UPCOMING ANNUAL MEETING,
SCHEDULED FOR NOVEMBER 25, 1996, YOU SHOULD BE AWARE OF THE
FOLLOWING IMPORTANT DEVELOPMENTS:

* The dissident stockholder group has recently distributed a new
  proxy statement retracting certain false statements contained in
  their prior communications to shareholders. All proxy cards 
  previously received by the group are invalid.

* Institutional Shareholder Services ("ISS"), the nation's
  leading independent shareholder advisory group, recently
  recommended a vote in favor of all of management's proposals, 
  including the merger with Andros, Inc., and rejected all of 
  the dissident group's proposals.

ISS stated:

"ISS supports this merger. While we believe the dissidents raise
important questions, their numbers are misleading." (emphasis
added)

"As for the price of the transaction, shareholders are giving up
38 percent of Novametrix for the potential of doubling their
earnings per share and having an equity stake in a much larger,
broader based company."

"Based on the favorable pricing, the strategic fit of the two
companies, the prospects for earnings growth, and the fairness
opinion rendered by Tucker Anthony, we believe the merger
agreement warrants shareholder support." (emphasis added)

     YOUR VOTE ON THE IMPORTANT ISSUES TO BE DECIDED 
     AT THE ANNUAL MEETING SHOULD BE BASED ON FACTS,
          NOT MISLEADING STATEMENTS AND NUMBERS.

At the Annual Meeting, decisions will be made that could
dramatically affect the future value of your Novametrix
investment. Those decisions should be based on facts, not
misleading statements and numbers.

You deserve to hear the real facts directly from Novametrix. On
November 12 and 13, senior management will be available at the
Sheraton Tara in Portland, Maine for one-on-one and small group
discussions at 9:00 a.m., 11:00 a.m., 1:00 p.m. and 3:00 p.m. In
addition, we will hold a large meeting on November 12, 1996 at
6:30 p.m. at the Tara. If you would like to attend any of these
meetings, please call 1-800-243-3444 to make a reservation.

- -------------------------- IMPORTANT --------------------------

If you have any questions about voting your shares, please call
Georgeson & Company Inc. TOLL FREE: 1-800-223-2064.

- ---------------------------------------------------------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission